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Numerous reports suggest that about one-third of patients 
with congestive heart failure do not have any abnormality of left 
ventricular systolic function. These patients presumably have 
heart failure on the basis of ventricular diastolic dysfunction. Our 
objective was to develop a comprehensive overview of published 
reports of the prevalence, clinical features and prognosis of 
diastolic heart failure and to offer recommendations for future 
studies. 
Thirty-one studies of patients with congestive heart failure 
with normal eft ventricular systolic function were published in 
the time period from January 1970 through March 1995. These 
studies were identified with the use of computer-based searches in 
relevant data bases. Among patients with congestive heart failure, 
the prevalence ofnormal ventricular systolic performance in the 
published reports varies widely from 13% to 74%; the reported 
annual mortality rate also varies from 1.3% to 17.5%. The criteria 
for congestive heart failure, its chronicity and the age of the study 
sample affect the reported prevalence and prognosis of the 
disorder. The clinical signs and symptoms of diastolic heart 
failure are similar to those of patients with systolic heart failure, 
underscoring the need for evaluation of ventricular systolic func- 
tion in patients with congestive heart failure. In the absence of any 
large-scale randomized clinical trial targeting these patients, the 
optimal treatment ofdiastolic heart failure is unclear. 
We conclude that the heterogeneity in previous studies of 
diastolic heart failure hinders the comparison of published re- 
ports. There is a need to conduct prospective, community-based 
investigations to better characterize the incidence, prevalence and 
natural history of diastolic heart failure. Randomized clinical 
trials are needed to determine optimal treatment s rategies. 
(J Am Coll Cardiol 1995;26:1565-74) 
It is increasingly being recognized that the syndrome of 
congestive heart failure (CHF) may arise in the absence of 
any abnormality of left ventricular systolic function (1-9). 
Patients with abnormalities of ventricular diastolic filling 
may not be able to produce an adequate cardiac output at 
the usual ventricular filling pressurcs despite the presence of 
normal ventricular systolic function (1-11); in these pa- 
tients, a compensatory elevation of ventricular filling pres- 
sures is necessary to maintain normal forward cardiac 
output. The elevated left atrial pressure is transmitted 
passively to the pulmonary vascular bed, resulting in pulmo- 
nary venous hypertension and its clinical manifestations. 
This syndrome has been termed diastolic heart failure (9). 
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The pathophysiologic and etiologic mechanisms of the 
syndrome and its treatment have been extensively reviewed 
previously (1-12). In the present review we focus on the 
epidemiologic ssues in evaluating the prevalence, clinical 
features and prognosis of diastolic heart failure. An over- 
view based on published reports of the prevalence, clinical 
features and prognosis of diastolic heart failure is presented 
along with recommendations for future studies. 
Thirty-one studies of CHF with normal left ventricular 
systolic function were published in the time period from 
January 1970 through March 1995 (13-43). These studies 
were identified with the use of computer-based searches in 
relevant data bases combined with other sources, such as 
references in the reports identified and in textbooks and 
published reports by experts in the field. The indexing terms 
congestive heart failure, ejection fraction, ultrasound, radionu- 
elide imaging and diastole were used for study retrieval; a 
search was made in English and non-English published 
reports (with the constraint of "human" subjects). Studies 
were included in the present review if all patients had CHF; 
ventricular systolic function was evaluated with standardized 
techniques (echocardiography or radionuelide or contrast 
ventriculography); the issue of normal left ventricular sys- 
tolic function in the presence of CHF was addressed; and 
the original data were published in a journal with peer 
review. Abstracts were excluded. 
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Methods Util ized in Previous Studies 
In this review, we summarize prior studies of diastolic heart 
failure with regard to study design, disease definition, imaging 
methods and study population characteristics (Table 1). We 
outline the methodoiogic problems encountered in defining 
the entities CHF, normal systolic function and diastolic dysfunc- 
tion, the three essential components of a diagnosis of diastolic 
heart failure. 
Study design and setting. Of the 31 studies (13-43) that 
described subjects with CHF who had normal eft ventricular 
systolic function, 8 (26%) were case series, and the remaining 
23 (74%) were clinical comparative studies that estimated the 
prevalence of normal ventricular systolic function in groups of 
patients with CHF (Table 1). Several of these studies were 
small and retrospective, and a majority were hospital based; 
only one study (40) was carried out in a community-based 
primary care setting. 
A consideration of the study design and setting is important 
in the interpretation of the results of these studies. Hospital 
admission constitutes a more severe degree of illness; there- 
fore, there is a referral bias in hospital-based studies. The 
results of hospital-based studies may be valid but are not 
generalizable to the outpatient with CHF. Hypotheses and 
disease associations emerging from case series and retrospec- 
tive clinical studies must be recognized as being "data derived" 
(there being no a priori hypothesis) and must be tested and 
confirmed prospectively in studies designed to address pecific 
issues (such as risk factors for diastolic heart failure) (44). 
Disease definition and patient selection. Criteria for diag- 
nosis of CHF. There is no single accepted efinition for the 
diagnosis of CHF (45). Clinical criteria used for the diagnosis 
of CHF are heterogeneous both in clinical trials (46) and in 
office practice (47). Of the 31 studies included in this review, 7 
(23%) did not explicitly state the criteria used for the diagnosis 
of CHF (18-20,30,40,42,43). Among the 24 studies that spec- 
ified the criteria for congestive heart failure, the lack of 
uniformity of criteria is striking (Table 1). One study (22) 
utilized three sets of clinical criteria (48-50) to define CHF; 
there was significant variation in the number of subjects 
considered to have CHF (from 32% to 56%) and in the 
prevalence of normal systolic function (from 34% to 40% of 
subjects with CHF) when different sets of criteria were used. 
Thus, the heterogeneity of diagnostic riteria for CHF may 
contribute substantially to the significant variation in preva- 
lence of diastolic heart failure among patients with CHF. 
Severity of CHF. It has been suggested that any definition of 
CHF must be reproducible and must include subjects with both 
mild and overt disease (51). In practice, even when specified 
criteria for CHF are used, subjects are dichotomized into those 
with definite CHF and those without CHF. Because subjects 
with mild heart failure are less likely to meet the criteria for 
definite CHF, there is an inherent selection bias in favor of 
more severe cases of CHF being included in such studies (52). 
Although such a bias may be unavoidable, its presence needs to 
be acknowledged, especially when prognosis of diastolic heart 
failure is evaluated. 
Source of patients with CHF within a medical facility and 
information regarding excluded subjects. Ideally, all consecutive 
subjects presenting to a medical facility with a diagnosis of 
heart failure must be included in a study designed to investi- 
gate the problem of diastolic heart failure. Only 9 studies of 31 
included all consecutive patients with CHF presenting to the 
concerned medical facility (21,27,29,31-33,39,42,43). Clini- 
cians do not order tests to estimate left ventricular function in 
all patients with CHF. Often such tests are ordered preferen- 
tially in the sicker patients (where a therapeutic decision may 
be based on the estimated ejection fraction) or in the relatively 
healthier subjects in whom the diagnosis of CHF itself is 
suspect. 
Occasionally, an imaging test (for ventricular systolic func- 
tion) may be ordered for a patient with CHF, but the result 
may be unsatisfactory and these patients excluded from the 
study. Information regarding the number of patients with CHF 
with unsatisfactory noninvasive studies is critical because such 
patients are often sicker than those with satisfactory studies 
(53). Nineteen studies did not provide details of patients with 
CHF with unsatisfactory noninvasive studies. In the 12 studies 
that did disclose this information, 16% to 42% of patients with 
CHF had inadequate or incomplete imaging studies. 
Selection bias is also introduced when study patients are 
obtained from a particular diagnostic laboratory within a 
medical facility. For instance, patients with CHF obtained 
from the cardiac atheterization laboratory are more likely to 
have coronary disease as the etiologic factor. A sampling frame 
that uses patients with CHF undergoing radionuclide imaging 
may differ from another that utilizes such patients undergoing 
echocardiography. Radionuclide tests are often obtained in 
patients with pulmonary disease who have poor quality echo- 
cardiograms. Such patients are more likely to have dyspnea 
due to pulmonary disease and, therefore, are more likely to 
have intact left ventricular systolic function. Conversely, an 
echocardiogram is often obtained at the bedside of a patient 
too sick to be sent to the radionuclide laboratory or one with 
significant valvular heart disease. 
Exclusion of other causes of dyspnea nd provision of evi- 
dence of diastolic dysfunction. Because the signs and symptoms 
of CHF are nonspecific, it is essential to exclude an alternative 
explanation for the symptoms and, if feasible, provide evidence 
of elevated left ventricular filling pressures before accepting a 
diagnosis of CHF with normal systolic function. Only 3 studies 
of the 31 reviewed provided etails regarding the exclusion of 
other causes of dyspnea (15,20,29). Significantly, in one study, 
11 (16%) of 69 patients with suspected CHF had a pulmonary 
cause of dyspnea (20). 
Presence of CHF with normal left ventricular systolic 
function is often treated as synonymous with the presence of 
"diastolic dysfunction," although this need not be the case. 
Only 6 (19%) of 31 studies assessed ventricular diastolic 
performance with imaging techniques to substantiate he pres- 
ence of diastolic dysfunction i patients with CHF and normal 
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systolic function (20,25,31,34,39,41 ); ventricular diastolic filling 
indexes (estimated noninvasively) were abnormal in 20% to 
62% of patients (20,25). This finding highlights the need to 
develop uniform criteria for diastolic dysfunction that must be 
satisfied before one can accept diastolic dysfunction as the 
pathophysiologic mechanism in a patient with CHF and nor- 
mal ventricular systolic function. 
Imaging methodology. Choice of imaging modality. Fifteen 
studies (48%) utilized echocardiography, 12(39%) radionu- 
clide ventriculography, and 4 (13%) contrast ventriculography 
for assessing ventricular systolic function (Table 1). The po- 
tential biases arising from the selection of an imaging modality 
have been referred to earlier. Furthermore, disagreement in 
estimates of ventricular ejection fraction by these methods is 
well recognized (54). One study (21), which provided etails of 
both radionuclide ventriculograms and echocardiograms, dem- 
onstrated isagreement between the results of the two inves- 
tigations. 
Variables for assessing systolic performance. Both echocar- 
diographic and radionuclide studies utilized ejection phase 
indexes (ejection fraction or fractional shortening) for evalu- 
ating ventricular systolic performance (Table 1). Ejection 
phase indexes are not measures of myocardial contractility and 
are significantly influenced by changes in loading conditions. 
Thus, a low ejection fraction in a patient with severe aortic 
stenosis may not indicate contractile dysfunction; recovery of 
ejection fraction is frequent after aortic valve replacement 
(55). Conversely, a normal ejection fraction in the setting of 
severe mitral regurgitation may not indicate normal myocar- 
dial contractility; rather, it may simply reflect a lowered 
ventricular afterload (56). Fractional shortening is further 
limited by the fact that it assesses only the basal portion of the 
left ventricle and is likely to be erroneous in the presence of 
wall motion abnormalities or conduction system disease. Only 
one study (33) provided several indexes of ventricular contrac- 
tility (including the relatively load-independent systolic blood 
pressure/end-systolic volume index). In that study, the preva- 
lence of normal ventricular systolic function varied from 34% 
to 45% depending on the particular index selected to define 
ventricular contractile dysfunction. 
Partition values for defining systolic dysfunction. Most stud- 
ies dichotomized patients with CHF into those with normal 
and abnormal systolic function. Such a scheme (in which 
patients are dichotomized) ignores the frequent coexistence of
systolic and diastolic mechanisms in the pathogenesis of CHF 
(3) and overlooks the fact that ejection phase indexes are 
continuous variables; normal values of these indexes may often 
blend into abnormal ones without a distinct threshold. The 
"cut points" of ejection phase indexes that were used for 
defining systolic dysfunction varied widely in these studies 
(Table 1), a factor that would influence the prevalence of the 
syndrome of CHF with "normal" systolic function. It has been 
suggested empirically (10) that an ejection fraction value of 
0.40 be used for distinguishing patients with CHF with pre- 
dominant systolic dysfunction from those with predominant 
diastolic dysfunction. There is no clear consensus in published 
reports regarding an optimal partition value for differentiating 
"predominant systolic" from "predominant diastolic" ventric- 
ular dysfunction. 
Timing of study. It is essential to obtain an estimate of 
ventricular systolic function during the episode of cardiac 
decompensation because left ventricular function may improve 
with time (57). Important contributory mechanisms toward 
CHF (e.g., acute mitral regurgitation due to ischemic papillary 
muscle dysfunction) may be identified only during the actual 
episode of pulmonary edema. This is the distinction between 
"being in congestive heart failure" and meeting the criteria for 
CHF ("having had congestive heart failure"). Only eight 
studies (26%) provided information regarding the timing of 
the test used to assess left ventricular systolic function (Table 
1). 
Number of estimates of left ventricular systolic function. All 
studies reviewed included a one-time assessment of ventricular 
systolic function. Spontaneous variation of ventricular systolic 
function has been observed in patients with CHF. In one-third 
of patients with CHF, the ejection fraction may vary by more 
than five percentage points over a period of 12 weeks (58). 
When the index being measured has significant intraindividual 
variation over time, it is important o obtain more than one 
measurement of that index. In patients with an ejection 
fraction in the range 0.40 to 0.55, potential for misclassification 
may exist if only a single estimate ("snapshot") of left ventric- 
ular function is obtained. 
Blinding of interpreter and reproducibility of measurements. 
Another major drawback of all but two studies (23,32) is the 
failure to provide specific information as to whether or not the 
assessment of ventricular function was performed with the 
observer "blinded" to all other clinical information regarding 
the patients. 
The reported reproducibility ofestimates of left ventricular 
ejection fraction by radionuclide ventriculography and echo- 
cardiography varies from 5 to 10 percentage points (54,59), 
The variability for estimation of ejection fraction with contrast 
ventriculography as been reported to be up to 15 percentage 
points (60). In this context, only one study (15) qualified its 
results with reports of reproducibility of estimating ejection 
fraction. 
Study sample characteristics. Age. All studies recruited 
subjects in the sixth to ninth decades of age (Table 1). The age 
of the study subjects is of importance because some disorders 
such as hypertensive hypertrophic ardiomyopathy are seen 
more often in the elderly (18,61). Studies in elderly patients are 
likely to reflect a higher prevalence of CHF with normal 
systolic function. Age is also an important factor to consider in 
evaluating the prognosis of subjects with CHF because mor- 
tality related to CHF increases in a graded manner with 
advancing age (62-65). 
Gender and race. Race and gender are other important 
determinants obe considered in evaluating the prevalence of 
diastolic heart failure and associated mortality trends. The 
prevalence of CHF is higher and prognosis worse in men (vs. 
women) (63.64) and in African-American patients (vs. white 
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patients) (66-68). In this context, 3studies (28,34,37) included 
only men, and 28 included both male and female patients. Only 
seven studies (17,23-25,29,32,41) provided information re- 
garding the racial origin of the subjects enrolled: four studies 
focused on African-American (32), Asian (23) and Spanish 
(29,41) patients, and three other studies (17,24,25) had a mixed 
sample of both white and African-American subjects. These 
differences in characteristics of the study population may 
account for some of the heterogeneity n the results of various 
studies of diastolic heart failure. 
Acute versus chronic CHF and duration of CHF. The dis- 
tinction of acute from chronic CHF is of importance in 
studying the prognosis of these patients. Patients with chronic, 
persistent CHF are likely to have fewer reversible features and 
consequently may have a worse prognosis than those in whom 
an acute episode resolves (e.g., CHF related to acute ischemia 
or severe hypertension). Only 17 studies (55%) provided 
information regarding the acuteness of CHF in study patients 
(Table 1). 
Among patients with chronic CHF, it is important to obtain 
information regarding the duration of symptoms; failure to 
consider disease duration can lead to a "lead time bias" (69). 
Patients who are diagnosed at an early stage of disease are 
likely to live longer than those with the same disease process 
identified at a more advanced stage. Such information was not 
available in any of the studies reviewed. 
Principal Findings in Published Reports 
Prevalence. The prevalence of diastolic heart failure in the 
community is unknown. Among patients with CHF, the prev- 
alence of normal ventricular systolic performance in published 
reports varies widely from 13% to 74% in clinical studies 
(Table 1). Despite the wide variation in reported prevalence, it 
is remarkable that a majority of studies report values -40%. 
These patients are presumed to have diastolic heart failure. 
The criteria used for defining CHF affect he reported preva- 
lence of diastolic heart failure (22). A study (43) that identified 
patients with CHF on the basis of diuretic intake for a 
diagnosis of CHF (without specifying the criteria for CHF) 
estimated a prevalence of normal ventricular systolic function 
of 74%. In view of the high (50%) false positive diagnosis of 
CHF in primary care (52), it is conceivable that some estimates 
of the prevalence of CHF with normal ventricular systolic 
function were inflated by the inclusion of patients without 
CHF. In addition, a careful perusal of Table 1 reveals that 
chronicity of CHF and the age of the study sample affect the 
reported prevalence of the disorder. Studies that included 
patients with acute and chronic CHF yielded intermediate 
prevalence stimates (25% to 40%) of normal ventricular 
systolic function (Table 1). In studies restricted to middle-aged 
patients with chronic CHF, the prevalence of normal ventric- 
ular systolic performance has been < 15% (28,42). Four studies 
that evaluated elderly patients with CHF reported a high 
prevalence (41% to 45%) of normal systolic function 
(23,27,33,37). 
Age-related trends in the prevalence of normal ventricular 
systolic function among patients with CHF were specifically 
examined in only two studies. The prevalence of normal 
ventricular systolic function was significantly lower in patients 
with CHF <65 years old than those >65 years old (6% vs. 34% 
and 12% vs. 30%) (23,39). 
Clinical features. Symptoms and signs. Eleven of 31 studies 
provided etails regarding the physical signs observed in patients 
with CHF and normal systolic function (15,17, 18,20, 
23,25,27,32,33,39,41). Both third and fourth heart sounds were 
frequently present. Distension of jugular veins was observed in 
<50% of patients. Five studies (18,23,25,27,39) commented on 
the presence of atrial arrhythmias; atrial fibrillation was seen in 
0% to 75% of patients. The prevalence of coronary disease varied 
from 5% to 67% in various studies. Between 11% and 83% of 
subjects were reported to be hypertensive (Table 1). 
Predictors of normal eft ventricular systolic function in pres- 
ence of CHF. Twelve studies provided information regarding 
the clinical predictors of normal systolic function in the 
presence of CHF by comparing characteristics of this group 
with those of patients with CHF and systolic dysfunction. The 
findings, shown in Table 2, reveal considerable disagreement 
among the studies. Clinical features (age, gender, hyperten- 
sion, alcohol intake or smoking status) and physical examina- 
tion (jugular venous distension, a third heart sound) failed to 
discriminate consistently between subjects with intact systolic 
function and those with systolic dysfunction. 
Prognosis. The reported annual mortality rate of patients 
with CHF and intact left ventricular systolic function has varied 
widely from 1.3% to 17.5% (Table 3) (16,24,27,28,36- 
38,70,71). The influences of etiology and subject selection 
(factors such as age or gender) on mortality could in part 
account for these disparate results. None of the studies pro- 
vided age-adjusted mortality rates. The three studies reporting 
the highest annual mortality rates may have been skewed by 
the choice of an unusually low partition value for abnormal 
ventricular systolic function in one study (24) and a very high 
mean age of subjects in the other two (27,37). The impact of 
the presence or absence of coronary artery disease on the 
survival of subjects with CHF and intact systolic function is also 
controversial, with one study reporting no impact (70) and 
another eporting a negative impact (36). The lowest reported 
annual mortality rate (1.3%) was in a study (38) that included 
subjects with isolated diastolic dysfunction (by excluding the 
presence of coronary disease); the mean age of patients in this 
study was also the lowest. Studies of patients with a mean age 
of 55 to 71 years (with a prevalence of coronary disease ranging 
from 14% to 67%) reported an annual mortality rate of 3% to 
9%. It is clear that the reported mortality rate of patients with 
diastolic heart failure is considerably lower than that of 
patients with systolic heart failure (with an annual mortality 
rate of 15% to 20%) (10). 
Patients with CHF on the basis of valvular heart disease 
(aortic stenosis or regurgitation) and who have normal left 
ventricular systolic function constitute a separate subgroup 
with a very high annual mortality rate (in excess of 25%) if the 
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Table 2. Clinical Predictors for Presence of Normal Left Ventricular Systolic Function in Patients With Congestive Heart Failure: Summary 
of Clinical Studies 
Study (ref no.) Factors Predicting Normal LV Function Factors Not Predictive 
Warnowicz et al. (16) 
Dougherty et al. (17) 
Bier et al. (21) 
Wong et al. (23) 
Kinney et al. (24) 
Aguirre et al. (25) 
Aronow et al. (27) 
Bareiss et al. (30) 
Stone et al. (31) 
Ghali et al. (32) 
Cocchi et al. (33) 
Taffet et al. (37) 
Takarada et al. (39) 
None 
HTN 
Admission blood pressure >160/100 mm Hg, 
paroxysmal nocturnal dyspnea, pedal edema 
Old age, female gender, atrial fibrillation, echo 
LVH 
None 
Old age, echocardiographic LVH and normal wall 
motion, absence of history_ of CAD or 
paroxysmal nocturnal dyspnea nd absence of S, 
Age > 80 yr, absence of S~ 
Age, acute onset, female gender, HTN, absence 
of jugular venous distension or cardiac 
enlargement 
None 
Female gender, obesity, absence of jugular venous 
distension, diastolic blood pressure > 105 mm 
Hg 
None 
None 
Age > 65 yr 
Age, gender, HTN 
Age, gender, diabetes mellitus, smoking status, alcohol intake, $3, 84, 
JVD. ECG LVH 
Gender. HTN, CAD 
HTN, diabetes mellitus, CAD, smoking status, alcohol intake 
Age, gender, HTN, 83, jugular venous distension, paroxysmal nocturnal 
dyspnea, CAD, alcohol intake, lung disease 
Gender, HTN, $4, jugular venous distension, exertional dyspnea, 
orthopnea 
Gender. HTN, atrial fibrillation 
S~, $4 
Mitral regurgitation 
Age, HTN, CAD, alcohol intake, smoking status, S 3, edema, cardiac 
enlargement, echocardiographic LVH 
Age, gender, HTN, CAD, jugular venous distension, 83 
Age, HTN, CAD, diabetes mellitus, alcohol intake 
Gender. HTN, atrial fibrillation 
ECG electrocardiographic; LVH left ventricular hypertrophy; S 3 and S 4 - third and fimrth heart sounds, respectively; other abbreviations a  in Table 1. 
valve disease is not corrected surgically (72,73). Further studies 
are required to identify the prognosis of patients with diastolic 
heart failure of different etiologies. 
Treatment. Only 1 of the 30 studies reviewed provided 
details regarding the selection of a specific therapeutic regimen 
and treatment-based differences in patient outcome (28). In 
that study, a trend toward a prolongation oflife with the use of 
hydralazine and isosorbide dinitrate was observed (vs. place- 
bo), but the sample size was too small to achieve statistical 
significance. A beneficial effect of enalapril was reported in a 
randomized trial (74) conducted in a small group of elderly 
patients with prior myocardial infarction and diastolic heart 
failure, but that study was limited by the nonblinded assess- 
ment of end points. A third randomized, placebo-controlled, 
crossover trial (75) utilizing verapamil reported a benefit, but 
the study was limited by the small sample size of 20 patients. In 
view of the paucity of clinical trials targeting patients with 
diastolic heart failure, the optimal treatment ofdiastolic heart 
failure remains unknown and empiric. 
Future Direct ions 
Diagnosis of diastolic heart failure. There is a lack of 
consensus among clinicians regarding what constitutes dia- 
stolic dysfunction (as measured by noninvasive means). The 
development of consensus criteria for diastolic heart failure 
would be an important step toward obtaining a reasonable 
estimate of the burden of diastolic heart failure in the com- 
munity because its prevalence and prognosis remain largely 
unknown despite the profusion of published reports on the 
subject. There is also a need to develop simple diagnostic tools 
for diastolic heart failure that have reasonable accuracy com- 
bined with ease of usage for clinical and epidemiologic studies. 
Currently used Doppler echocardiographic indexes of diastolic 
function derived from the study of ventricular filling dynamics 
are limited by their load dependence and by "the lack of 
validation of most of the variables by comparison to appropri- 
ate independent standards" (76). Better assessment ofventric- 
ular systolic and diastolic function with load-independent 
indexes hould enable the formulation of criteria that permit a 
distinction among systolic, diastolic and combined (systolic and 
diastolic) mechanisms of cardiac failure. The role of newer 
methods of evaluating ventricular systolic (77,78) and diastolic 
(79-85) function remains to be determined. Furthermore, any 
diagnostic test must be interpreted with the observer blinded 
to clinical information and with the evaluation of test repro- 
ducibility (interobserver and intraobserver). 
Incidence, prevalence and prognosis. The incidence and 
prevalence of diastolic heart failure can be assessed in pro- 
spective community-based cohort studies that utilize uniform 
criteria for the condition. Such studies can help in the identi- 
fication of risk factors for diastolic heart failure. All consecu- 
tive patients with heart failure must be included, and care 
taken to ensure adequate representation f minority popula- 
tions. Studies investigating the prognosis of diastolic heart 
failure must utilize a sample of patients at a similar point in the 
course of disease. Morbidity and mortality data in such studies 
must be adjusted for age, relevant prognostic variables (e.g., 
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Table 3. Mortality Rate and Its Determinants in Patients With Congestive Heart Failure and Normal Left Ventricular Systolic Function 
Cumulative 
Mortality. Rate Average 
Follow-Up Mean Age (q4) Annual 
No. of Duration of Pts CAD (~k Mortality Mechanism of 
Study (ref no.) Pts (yr) (yr) of pts) I yr 4 yr Rate (%,) Death Predictors of Mortality 
Warnowicz et al. (16) 16 0.75 63 100 
Kinney et al. (24) 44 4 64 NR 
Aronow et al. (27) 68 4 84 100 
Cohn et al. (28) 83 5.7 59 26 
Judge et al. (36) 284 6 56 67 
Taffet et al. (37) 40 3 82 65 25 ~ 45* 15 45% cardiac 
(at 3 yr/ (sudden cardiac 
death 20%, pump 
failure 73%) 
Brogan et al. (38) 53 5.(~ 55 0 3 5 1.3 44% cardiac 
Setaro et al. (70) 52 7 71 52 20* 40* 6.5 90% cardiac (mostly 
pump failure) 
Ghali et al. (71) 22 4 6(I 14 22 36 9 75% cardiac (pump 
failure 84%, 
sudden cardiac 
death 16%) 
25 NR NR All cardiac (MI NR 
75 %, sudden 
cardiac death 
25%) 
35 70 17.5 Majority cardiac NR 
22 56 14 92% cardiac Age, HTN 
8 27 ~ 8 84% cardiac Ventricular tachycardia 
(sudden cardiac on Holter 
death 75%, pump 
failure 25%) 
5* 12' 3 NR Wall motion score, no. 
of diseased vessels, 
age, HTN, lung 
disease, diabetes 
mellitus, LVEDP, 
other vascular 
disease 
Age, recurrent 
admissions 
NR 
CAD not predictive 
HTN 
*Data obtained by interpolation of Kaplan-Meier survival curves. Pts = patients; other abbreviations a  in Table 1. 
etiology, gender, race and acuteness of heart failure) and 
treatment. 
Treatment and prevention. There is a need for randomized 
clinical trials to determine the appropriate treatment for 
patients with established iastolic heart failure. Such trials 
must utilize objective, clinically relevant outcome criteria that 
must be specified a priori. The assessment of outcomes must be 
"blinded," and the results adjusted for extraneous prognostic 
variables (besides treatment). 
Prevention of diastolic heart failure is feasible with vigorous 
efforts to prevent and control important underlying conditions, 
such as hypertension, coronary disease, diabetes metlitus and 
obesity. The elderly and African-Americans are two segments 
of the U.S. population that are at high risk for developing 
diastolic heart failure. There is a need to develop safe and 
cost-effective methods for screening high risk patients for the 
early detection of CHF (and predisposing conditions uch as 
left ventricular hypertrophy) with a view to preventing the 
morbidity and mortality associated with diastolic heart failure. 
Specific approaches aimed at reversing the molecular events 
that mediate cardiac hypertrophy (e.g., drug therapy for re- 
gressing left ventricular hypertrophy or gene therapy for 
familial hypertrophic cardiomyopathy) need to be investigated 
in view of recent evidence that regression of cardiac hypertro- 
phy is associated with improved cardiovascular outcome (86). 
Conclus ions 
The syndrome of diastolic heart failure is common in 
clinical practice. The signs and symptoms of the disorder are 
quite similar to those of patients with CHF with left ventricular 
systolic dysfunction. However, the prognosis of these patients 
is different from that of subjects with systolic heart failure, 
underscoring the need for evaluation of ventricular systolic 
function in patients with CHF. 
Previous studies of diastolic heart failure differ consid- 
erably with regard to patient selection criteria, diagnostic 
criteria for CHF, quantitative methods for assessment of 
ventricular systolic function and duration of follow-up. 
Such heterogeneity in prior studies makes the comparison 
of published reports regarding the prevalence of this disor- 
der and its natural history difficult. There is a need to 
evaluate these patients prospectively in community-based 
studies (with uniform criteria for the presence of CHF, 
normal systolic function and diastolic dysfunction) to better 
characterize the disorder and its natural history. There is 
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also a need for randomized clinical trials to determine the 
optimal treatment for patients with established diastolic 
heart failure. 
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